Patents by Inventor Fumi HIGUCHI

Fumi HIGUCHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11377453
    Abstract: An object of the present invention is to provide a compound with an excellent JAK1 inhibitory activity. The compound of the invention has JAK1 inhibitory activity, and thus, immunosuppressive effect, anti-inflammatory effect, anti-proliferative effect and so on, and is useful in the treatment of the diseases, for example, rheumatoid arthritis, inflammatory bowel disease, psoriasis, vasculitis, bronchial asthma, chronic obstructive pulmonary disease, eosinophilic sinusitis and nasal polyp.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: July 5, 2022
    Assignee: NIPPON SHINYAKU CO., LTD.
    Inventor: Fumi Higuchi
  • Publication number: 20210017191
    Abstract: An object of the present invention is to provide a compound with an excellent JAK1 inhibitory activity. The compound of the invention has JAK1 inhibitory activity, and thus, immunosuppressive effect, anti-inflammatory effect, anti-proliferative effect and so on, and is useful in the treatment of the diseases, for example, rheumatoid arthritis, inflammatory bowel disease, psoriasis, vasculitis, bronchial asthma, chronic obstructive pulmonary disease, eosinophilic sinusitis and nasal polyp.
    Type: Application
    Filed: September 29, 2020
    Publication date: January 21, 2021
    Applicant: NIPPON SHINYAKU CO., LTD.
    Inventor: Fumi HIGUCHI
  • Patent number: 10822350
    Abstract: An object of the present invention is to provide a compound with an excellent JAK1 inhibitory activity. The compound of the invention has JAK1 inhibitory activity, and thus, immunosuppressive effect, anti-inflammatory effect, anti-proliferative effect and so on, and is useful in the treatment of the diseases, for example, rheumatoid arthritis, inflammatory bowel disease, psoriasis, vasculitis, bronchial asthma, chronic obstructive pulmonary disease, eosinophilic sinusitis and nasal polyp.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: November 3, 2020
    Assignee: NIPPON SHINYAKU CO., LTD.
    Inventor: Fumi Higuchi
  • Publication number: 20190048023
    Abstract: An object of the present invention is to provide a compound with an excellent JAK1 inhibitory activity. The compound of the invention has JAK1 inhibitory activity, and thus, immunosuppressive effect, anti-inflammatory effect, anti-proliferative effect and so on, and is useful in the treatment of the diseases, for example, rheumatoid arthritis, inflammatory bowel disease, psoriasis, vasculitis, bronchial asthma, chronic obstructive pulmonary disease, eosinophilic sinusitis and nasal polyp.
    Type: Application
    Filed: February 28, 2017
    Publication date: February 14, 2019
    Applicant: NIPPON SHINYAKU CO., LTD.
    Inventor: Fumi HIGUCHI